Analyzing Growth Prospects: Global Cancer Diagnostics Market to grow at a CAGR of 9.43% by 2028, DelveInsight Estimates | Pillar Biosciences, Inc., Hologic Inc., CD Genomics, Natera, Inc., Agendia Inc., Biodesix Inc., INOVIQ Ltd., HTG Molecular Diagnostic

As per DelveInsight's assessment, the Cancer Diagnostics Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Cancer Diagnostics have been used, which is expected to drive the demand for Cancer Diagnostics in the upcoming years.

DelveInsight's "Cancer Diagnostics Market" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Cancer Diagnostics companies actively working in the market.

Cancer Diagnostics Overview
https://www.delveinsight.com/sample-request/cancer-diagnostic-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cancer To properly control cancer and its progression, a diagnostic procedure is required. No single test can reliably identify cancer; instead, a comprehensive evaluation often entails a physical examination, a detailed history, and diagnostic testing. Efficient diagnostic testing is utilized to plan for and assess the efficacy of treatment, track the course of the disease, and confirm or rule out its existence. Cancer diagnostic techniques can involve imaging, endoscopic examination, tumor biopsy, and laboratory testing.

Cancer Diagnostics Market Insights
Globally increasing cancer cases are the main causes driving demand for cancer diagnostics. The market for cancer diagnostics is also anticipated to be driven by technical advancements in cancer diagnostic devices, a rise in product releases, an increase in company growth efforts among major players, and other factors.
DelveInsight Analysis: The Global Cancer Diagnostics market size is anticipated to reach ~USD 214 billion by 2028 with a growing CAGR of 9.43% during the forecasted period (2023-2028).

To know more about why North America is leading the market growth in the Cancer Diagnostics market, get a snapshot of the report Cancer Diagnostics Market Trends
https://www.delveinsight.com/report-store/cancer-diagnostic-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Cancer Diagnostics Market Report
• In November 2021, Hologic, Inc. commercially launched its new Genius™ Digital Diagnostics System in Europe. The Genius Digital Diagnostics System is the next generation of cervical cancer screening that combines deep learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells in women.
• In June 2021, NeoGenomics completed its acquisition of Inivata Ltd, a global, commercial-stage liquid biopsy platform company headquartered in Cambridge, England.
• In August 2020, HTG Molecular Diagnostics, Inc. signed a commercialization and distribution agreement (Master Agreement) with QIAGEN Manchester Limited, a wholly-owned subsidiary of QIAGEN N.V. for companion diagnostic (CDx) assays based on HTG EdgeSeq, HTG's novel RNA platform.

To read more about the latest highlights related to Cancer Diagnostics, get a snapshot of the key highlights entailed in the Cancer Diagnostics Market Forecast Report
https://www.delveinsight.com/sample-request/cancer-immunotherapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key Players in the Cancer Diagnostics Market
Some of the key market players operating in the Cancer Diagnostics market include- Pillar Biosciences, Inc., Hologic Inc., CD Genomics, Natera, Inc., Agendia Inc., Biodesix Inc., INOVIQ Ltd., HTG Molecular Diagnostics Inc., Bio-Rad Laboratories, Inc., Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Abbott, General Electric Company, Thermo Fisher Scientific Inc., NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Guardant Health, Illumina, Inc., QIAGEN, and others.

COVID-19 Impact Analysis on the Cancer Diagnostics Market
https://www.delveinsight.com/sample-request/cancer-diagnostic-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
According to estimates, North America held a significant 42% share of the global market for cancer diagnostics in 2020 and is expected to maintain its dominance for the duration of the forecast. This dominance can be attributed to a number of important causes, including the increase in cancer incidence, the existence of important manufacturers, a well-established healthcare system, and growing public understanding of cancer and how to treat it.
Additionally, In the upcoming years, technological advancement in the creation of various cancer diagnostic products will also benefit the industry. The market for cancer diagnostics will grow as a result of the use of Artificial Intelligence (AI) technology into cancer care to increase the precision, speed, and efficiency of cancer detection. So, during the projected period, the market for Cancer Diagnostics is anticipated to continue expanding (2023-2028).

Scope of the Cancer Diagnostics Market Report
• Coverage: Global
• Study Period: 2020-2028
• Cancer Diagnostics Market Segmentation By Type: Product Type [Reagent & Kits and Instruments], and Services
• Cancer Diagnostics Market Segmentation By Technique: (Molecular Diagnostics [Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescent In-Situ Hybridization (FISH), Microarray, and Immunohistochemistry]
• Cancer Diagnostics Market Segmentation By End User: Hospitals And Clinics, Specialty Centers, And Others
• Cancer Diagnostics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Cancer Diagnostics Companies: Pillar Biosciences, Inc., Hologic Inc., CD Genomics, Natera, Inc., Agendia Inc., Biodesix Inc., INOVIQ Ltd., HTG Molecular Diagnostics Inc., Bio-Rad Laboratories, Inc., Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Abbott, General Electric Company, Thermo Fisher Scientific Inc., NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Guardant Health, Illumina, Inc., QIAGEN, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the Cancer Diagnostics market are set to emerge as the trendsetter explore @ Cancer Diagnostics Manufacturer
https://www.delveinsight.com/sample-request/cancer-diagnostic-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Cancer Diagnostics Market Report Introduction
2 Cancer Diagnostics Market Executive summary
3 Regulatory and Patent Analysis
4 Cancer Diagnostics Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Cancer Diagnostics Market
7 Cancer Diagnostics Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Cancer Diagnostics Market Drivers
11. Cancer Diagnostics Market Barriers
12. Project Approach
13. About DelveInsight

Interested in knowing how the Cancer Diagnostics market will grow by 2028? Click to get a snapshot of the Cancer Diagnostics Market Analysis
https://www.delveinsight.com/sample-request/cancer-diagnostic-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Latest Reports Offered By DelveInsight:

Oncology Drugs Market
https://www.delveinsight.com/report-store/oncology-drugs-market
Oncology Drugs Market By Therapy Type (Chemotherapy, Hormonal Therapy, Targeted Therapy [Gene Therapy And Immunotherapy], And Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancers, And Others), By End User (Hospitals, Specialty Clinics, And Others), and by geography is estimated to grow at a healthy CAGR forecast till 2028 due to rising prevalence of various cancers such as lung and breast cancers and growing demand for targeted therapies for cancer treatment.

Biologics Market
https://www.delveinsight.com/report-store/biologics-market
Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseases, And Others), By Manufacturing Type (In-House And Outsourced), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to rising prevalence of autoimmune disorders such as rheumatoid arthiritis and genetic disorders.

Biosimilar Market
https://www.delveinsight.com/report-store/biosimilars-market
Biosimilars Market By Product Class (Monoclonal Antibodies, Recombinant Hormone/Proteins, Anti-Inflammatory Agents, Immunomodulators, And Others), By Manufacturing Type (In-House And Outsourced/Contract), By Application (Autoimmune Diseases, Blood Disorders, Oncology, Infectious Diseases, And Others), by geography, is projected to expand at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders such as autoimmune disorders, cancers, among others and increasing demand for biosimilar drugs owing to their cost-effectiveness.

Cancer Immunotherapy Market
https://www.delveinsight.com/report-store/cancer-immunotherapy-market
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines, Checkpoint Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By End-User (Hospitals And Clinics, Specialty Centers, And Others), and by geography is expected to rise at a significant CAGR forecast till 2027 owing to the accelerating prevalence of cancers and surging healthcare expenditure across the globe

Companion Diagnostics Market
https://www.delveinsight.com/report-store/companion-diagnostics-market
Companion Diagnostics Market By Type (Product [Assays, Kits & Reagents And Instruments], and Services), Technology (Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, and Others), End-User (Hospitals, Diagnostic Labs, and Others), and Geography is expected to grow at a noteworthy CAGR till 2028 owing to the increase in the cancer burden across the globe and the growing focus on personalized medicines.

Contact Us
Gaurav Bora
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/medical-devices

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.